CoChat

Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin

Shah, Preeti, Gau, Yael, Sabnis, Gauri · 2014 · Breast Cancer Research and Treatment

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Loss of ERα in breast cancer correlates with poor prognosis, increased recurrence rates, and higher incidence of metastasis. Epigenetic silencing of E-cadherin (loss of which is associated with more invasive phenotype) is observed in metastatic cell lines and invasive breast cancers. Here, we are showing that entinostat (ENT) can reverse epithelial to mesenchymal transition (EMT), which is considered to be a first step in the process of metastases formation. Triple-negative breast cancer cells such as MDA-MB-231 and Hs578T show a basal phenotype characterized by loss of E-cadherin expression and higher expression of mesenchymal markers such as N-cadherin and vimentin along with transcriptional repressors such as twist and snail. When MDA-MB-231 and Hs578T cells or tumors were treated with ENT, E-cadherin transcription was increased along with reduction in N-cadherin mRNA expression. Chromatin immunoprecipitation assay showed that treatment of MDA-MB-231 and Hs578T cells increased the activation of E-cadherin promoter by reducing the association of twist and snail with the E-cadherin (CDH1) promoter and downregulated both the snail and twist. ENT also inhibited cell migration in vitro. In addition, phosphorylation of vimentin was increased, as well as remodeling of vimentin filaments. ENT treatment also reduced formation of tubulin-based microtentacles, which help floating cells attach to other surfaces. These findings suggest that ENT can reverse EMT and may reduce the formation of metastasis.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10549-013-2784-7

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 40 · Cited by 86

Metadata

Authors
Shah, P., Gau, Y., & Sabnis, G.
Affiliations
University of Maryland, Baltimore (US)
Corresponding author
Sabnis, Gauri
Venue
Breast Cancer Research and Treatment
Published
2013-12-05
Volume
143
Issue
1
Pages
99-111
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
OpenAlex
W2035131746
Cited by
86
References
40
Citations by year
2026: 6 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 13 · 2020: 3 · 2019: 10 · 2018: 10 · 2017: 6 · 2016: 6 · 2015: 3 · 2014: 9
FWCI
3.21
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Breast Cancer Research and Treatment (publishedVersion)
  • PubMed (publishedVersion)
Funders
Susan G. Komen
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
entinostat, histone deacetylase inhibitors, epithelial-mesenchymal transition, E-cadherin, breast cancer, triple-negative breast cancer, metastasis, epigenetic silencing, Twist, snails, N-cadherin, vimentin, cell migration, MDA-MB-231 cells, Hs578T
MeSH terms
Snail Family Transcription Factors, Benzamides, Breast Neoplasms, Cell Movement, DNA Helicases, DNA-Binding Proteins, Female, Humans, Promoter Regions, Genetic, Protein Binding, Pyridines, Transcription Factors, Cadherins, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Twist-Related Protein 1, Histone Deacetylase Inhibitors, Epithelial-Mesenchymal Transition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. https://app.cochat.ai/papers/10.1007/s10549-013-2784-7
The paper
Shah, P., Gau, Y., & Sabnis, G. (2014). Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-013-2784-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.